Magnetic Resonance Imaging (MRI) Guided and Focused Ultrasound Devices Market Report 2025

The magnetic resonance imaging (MRI)-guided focused ultrasound devices market size has grown rapidly in recent years. It will grow from $2.8 billion in 2024 to $3.14 billion in 2025 at a compound annual growth rate (CAGR) of 12%. The growth during the historic period was driven by increasing demand for non-invasive treatments, rising prevalence of neurological disorders, growing awareness of early disease detection, expanding clinical trial activity, and favorable reimbursement developments.

The magnetic resonance imaging (MRI)-guided focused ultrasound devices market size is expected to see rapid growth in the next few years. It will grow to $4.87 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth during the forecast period is fueled by an aging population, increasing adoption in oncology care, rising investments in healthcare infrastructure, expanding applications in pain management, and growing government support. The primary trends in the forecast period include advancements in imaging precision, integration of artificial intelligence (AI) for treatment planning, miniaturization and portability of systems, improved real-time thermal monitoring, development of portable and cost-efficient devices, and enhanced patient safety and non-invasive capabilities.

The growing incidence of neurological disorders is expected to drive the expansion of the magnetic resonance imaging (MRI)-guided focused ultrasound devices market in the coming years. Neurological disorders, which impact the brain, spinal cord, and nerves, result in a variety of symptoms such as cognitive, motor, and sensory impairments. The increasing prevalence of these disorders is largely due to the aging global population, as the natural aging process weakens neuronal function, reduces brain plasticity, and increases oxidative stress, all of which contribute to the onset and progression of neurological conditions. MRI-guided focused ultrasound devices support the diagnosis of neurological disorders by providing real-time imaging alongside non-invasive treatment capabilities, making them effective for precisely targeting affected areas of the brain. These devices improve diagnostic accuracy and treatment planning by offering high-resolution visualization and focused therapy, ultimately leading to better patient outcomes and clinical efficiency. For instance, the National Health Service (NHS) reported in July 2024 that 487,432 patients had been diagnosed with dementia, a progressive condition that affects memory, thinking, and daily activities, marking an increase of 3,155 cases since May 2024. Thus, the rising prevalence of neurological disorders is driving the growth of the MRI-guided focused ultrasound devices market.

Leading companies in the MRI-guided focused ultrasound devices market are focusing on developing advanced products, such as next-generation MR-guided focused ultrasound systems, to enhance precision, broaden clinical applications, and improve patient outcomes. These systems combine real-time MRI imaging with high-intensity focused ultrasound, offering better precision, automation, usability, and expanded clinical capabilities compared to earlier models. For example, in January 2024, Insightec Ltd., an Israel-based medical technology company, introduced the Exablate Prime system, an advanced MR-guided focused ultrasound (MRgFUS) platform. The system integrates intelligently designed algorithms, automated workflows, and seamless connectivity with hospital systems such as PACS, enabling remote planning and technical support from physicians. Its enhanced computing architecture allows for up to 150 reports, and it includes a high-resolution monitor for optimized imaging, along with a cross transducer designed for optimal performance during MR-guided procedures. Built on a decade of research and user feedback, the Exablate Prime system aims to provide unparalleled precision in neurosurgical treatments, including those for essential tremor and Parkinson’s disease, while reducing procedure times and improving operational efficiency.

In February 2025, Grovecourt Capital Partners LLC, a US-based investment firm, acquired IMRIS Imaging Inc. for an undisclosed amount. Through this acquisition, Grovecourt Capital Partners aims to expand its portfolio in medical imaging and advanced surgical technologies, strengthening its position in high-growth healthcare markets. The acquisition also grants Grovecourt access to IMRIS’s expertise in MRI-guided and hybrid operating room solutions. IMRIS Imaging Inc. is a US-based manufacturer specializing in MRI-guided focused ultrasound devices.

Major players in the magnetic resonance imaging (MRI) guided and focused ultrasound devices market are Medtronic plc, Siemens Healthineers, Koninklijke Philips N.V., Arrayus Technologies Inc., Merz Pharmaceuticals GmbH, Samsung Medison Co. Ltd., InSightec Ltd., EDAP TMS S.A., Image Guided Therapy S.A., Alpinion Medical Systems Co. Ltd., SonaCare Medical, LLC, Profound Medical Inc., Mianyang Sonic Electronic Ltd., Daxsonics Ultrasound, Verasonics, Inc., Cardiawave, Focal One, FUS Instruments Inc., Sonic Concepts Inc., and Theraclion SA.

North America was the largest region in the magnetic resonance imaging (MRI)-guided focused ultrasound devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in magnetic resonance imaging (MRI)-guided focused ultrasound devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the magnetic resonance imaging (MRI)-guided focused ultrasound devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Magnetic resonance imaging (MRI)-guided focused ultrasound devices are advanced medical technologies that combine MRI imaging with high-intensity focused ultrasound to precisely target specific tissues. These devices provide non-invasive treatment by delivering focused energy while continuously monitoring the treatment area with MRI for accuracy and safety. They help minimize damage to surrounding healthy tissues and reduce the need for surgical intervention.

The primary types of MRI-guided focused ultrasound devices are MRI-guided systems and focused ultrasound systems. MRI-guided systems use MRI technology to visualize and monitor internal tissues and organs in real time, allowing clinicians to guide, plan, and assess procedures with high precision and without ionizing radiation. Based on treatment types, these devices are classified as thermal ablation, non-thermal ablation, and drug delivery systems, utilizing technologies such as MRI-guided ultrasound, focused ultrasound therapy, ultrasound imaging systems, and combination systems. Applications span oncology, neurology, cardiology, urology, and others, serving end users including hospitals, clinics, ambulatory surgical centers, and research and academic institutes.

The magnetic resonance imaging (MRI)-guided focused ultrasound devices market research report is one of a series of new reports that provides magnetic resonance imaging (MRI)-guided focused ultrasound devices market statistics, including the magnetic resonance imaging (MRI)-guided focused ultrasound devices industry global market size, regional shares, competitors with the magnetic resonance imaging (MRI)-guided focused ultrasound devices market share, detailed magnetic resonance imaging (MRI)-guided focused ultrasound devices market segments, market trends, and opportunities, and any further data you may need to thrive in the magnetic resonance imaging (MRI)-guided focused ultrasound devices industry. This magnetic resonance imaging (MRI)-guided focused ultrasound devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The magnetic resonance imaging (MRI)-guided focused ultrasound devices market consists of revenues earned by entities by providing services such as image-guided therapy procedures, non-invasive treatment planning, system maintenance, and clinical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The magnetic resonance imaging (MRI)-guided focused ultrasound devices market also includes sales of transducers, treatment planning software, patient positioning systems, and related accessories and consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.